Vitamin D deficiency affects an estimated one billion people globally, driven by indoor lifestyles, northern latitudes, and the melanin that protects darker skin from UV damage. This article explains how sun exposure, latitude, and supplementation interact to determine your vitamin D status.

How the Skin Produces Vitamin D

Vitamin D synthesis begins when UVB radiation (wavelength 280–315 nm) penetrates the outer layers of skin and strikes 7-dehydrocholesterol (7-DHC), a cholesterol derivative present in skin cells. The UV energy converts 7-DHC into previtamin D3, which then isomerizes spontaneously into vitamin D3 (cholecalciferol) over a matter of hours. This vitamin D3 enters the bloodstream and travels to the liver, where it is converted to 25-hydroxyvitamin D [25(OH)D] — the form measured in clinical blood tests. A second conversion in the kidney produces the active hormone, 1,25-dihydroxyvitamin D, which regulates calcium absorption, bone metabolism, and many other physiological processes. The entire synthesis pathway from skin exposure to circulating active hormone takes approximately 24–48 hours. Critically, the skin has a natural safety mechanism: prolonged UVB exposure degrades previtamin D3 and its precursors, preventing toxic accumulation from sun alone. This is why vitamin D toxicity never occurs from sun exposure — only from supplementation doses far above physiological needs.

Latitude, Season, and the Solar Angle Effect

The solar zenith angle — how high the sun is in the sky — determines whether UVB reaches Earth's surface at all. At low solar angles (early morning, late afternoon, and winter months at higher latitudes), UVB photons must travel through a much greater thickness of atmosphere, and the ozone layer absorbs virtually all of them before they reach skin. Above approximately 35° North or South latitude, this effect is strong enough in winter that essentially no vitamin D synthesis occurs from October through March — a phenomenon called the vitamin D winter. In Boston (42°N), Atlanta (33°N) barely avoids the vitamin D winter; in Chicago (42°N), Seattle (47°N), and anywhere in Canada, winter sun exposure produces negligible vitamin D regardless of duration. In summer at the same latitudes, solar angles are favorable and even brief midday exposures can produce thousands of IU of vitamin D equivalent. Season and latitude together account for the majority of vitamin D variation within a population — more so than diet, which provides very little D3 from natural food sources alone. This geographic reality explains why wintertime supplementation is clinically important for anyone living north of approximately 35°N.

How Skin Type Affects Synthesis

Melanin — the pigment that gives skin its color — is an efficient absorber of UVB radiation. Darker skin has more melanin, which protects against UV damage and skin cancer but also dramatically slows vitamin D synthesis. A person with Fitzpatrick Type VI skin (deeply pigmented) may need 5–10 times longer sun exposure than a Type I (very fair) person to produce the same amount of vitamin D under identical conditions. This biological fact has profound public health implications: populations with ancestral origins in high-UVB equatorial regions who now live at higher latitudes face the greatest vitamin D deficiency risk. In a clinical study of Boston-area adults, over 40% of Black adults had vitamin D deficiency (below 20 ng/mL) versus approximately 4% of white adults — a disparity driven largely by melanin's interaction with low-solar-angle UVB. The Fitzpatrick scale used in this calculator was originally developed for predicting UV sensitivity in dermatology, but it serves as a practical proxy for melanin content and its effect on vitamin D synthesis rates. For individuals with Types IV–VI, supplementation is especially important in any season or latitude where sun exposure is limited.

Optimal Blood Levels and Supplementation Dosing

The clinical definition of vitamin D status has evolved significantly over the past two decades. The Institute of Medicine (now National Academy of Medicine) sets the deficiency threshold at 20 ng/mL (50 nmol/L), the level needed to prevent rickets and osteomalacia. The Endocrine Society, which focuses on optimal rather than minimum function, considers 30 ng/mL as the lower bound of sufficiency and recommends 40–60 ng/mL as optimal for most adults — a range associated with maximally suppressed parathyroid hormone and optimal calcium absorption. Achieving and maintaining these levels through supplementation follows a reasonably predictable pharmacokinetics model: each additional 100 IU/day of vitamin D3 raises serum 25(OH)D by approximately 1 ng/mL over 2–3 months in a person of average weight. A person with a current level of 22 ng/mL who wants to reach 50 ng/mL needs to close a 28 ng/mL gap — requiring roughly 2,800 IU/day of supplementation. Body weight significantly affects this relationship: heavier individuals distribute vitamin D across a larger fat mass, requiring higher doses to achieve the same serum level. The Tolerable Upper Intake Level set by the NAM is 4,000 IU/day for most adults, though doses up to 10,000 IU/day are used therapeutically under medical supervision without well-documented toxicity in most studies. Toxicity (hypercalcemia) from vitamin D supplementation has been reported primarily at sustained doses above 40,000 IU/day over months.

Who Is Most at Risk of Deficiency

Vitamin D deficiency is most prevalent in populations with limited sun exposure, impaired synthesis, or increased metabolic demand. Older adults face deficiency risk for multiple compounding reasons: skin thins with age and produces less 7-DHC per unit of UVB; kidney conversion to active hormone declines; and reduced time outdoors limits sun exposure. Adults over 70 may need twice the supplementation of younger adults to achieve the same serum level. People with dark skin (Fitzpatrick Types IV–VI) living at latitudes above 35°N are at high risk year-round, and especially in winter, due to the melanin effect described above. Obesity is a significant risk factor because fat tissue sequesters vitamin D away from the bloodstream, requiring higher doses to achieve optimal serum levels. Malabsorption conditions — celiac disease, Crohn's disease, gastric bypass surgery — impair intestinal absorption of fat-soluble vitamins including vitamin D. People who cover most of their skin for cultural or religious reasons, or who consistently use high-SPF sunscreen on all exposed skin, produce little or no cutaneous vitamin D regardless of time outdoors. Exclusive breastfeeding without supplementation is also a deficiency risk for infants, since human breast milk is low in vitamin D — the American Academy of Pediatrics recommends 400 IU/day supplementation for all breastfed infants from the first days of life.